Enovix Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $35.9M+55.5% YoYTTM through 5 Jul 2026
Net Income -$170MTTM through 5 Jul 2026
Free Cash Flow -$124.2MTTM through 5 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 20.4% |
| EBITDA Margin | -392.7% |
| Operating Margin | -577.6% |
| Net Margin | -473.9% |
Returns
-71.2%ROE
-20.6%ROA
Balance Sheet Health
Debt / Equity2.20x
Current Ratio10.97x
Net Debt$790K
Cash & Equivalents$33.7M
Quality Metrics
Altman Z-Score-1.18
Piotroski F-Score4 / 9
FCF Margin-346.2%
Rule of 40-337.5
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $31.8M
Diluted EPS-$0.79TTMFY2025: $-0.75
Dividend
No dividend
Capital Allocation
Capex Intensity46.9%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.